AnalyzeDirect O’Brien TJ, Miles K, Ware R, Cook MJ, Binns DS, Hicks RJ. The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy. J Nucl Med. June 2008;49(6):931-937.
Full Text – Open Access
Publication Date
June 2008
How Analyze was Used
“Subtraction ictal SPECT coregistered to MR (SISCOM) images were constructed using an offline Unix-based workstation with commercial image-analysis software packages (ANALYZE).”
Keywords
Adolescent
Adult
Aged
Australia/epidemiology
Chronic Disease
Cohort Studies
Cost-Benefit Analysis
Epilepsies, Partial/economics/epidemiology/radionuclide imaging/surgery
Female
Fluorodeoxyglucose F18/diagnostic use/economics
Humans
Male
Middle Aged
Positron-Emission Tomography (PET)/economics
Preoperative Care/economics
Prevalence
Radiopharmaceuticals/diagnostic use/economics
Author Affiliation(s)
Departments of Medicine, Surgery, and Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia. (TJO)
Brighton and Sussex Medical School, University of Sussex, Brighton, UK. (KM)
Centre for Molecular Imaging, Peter MacCallum Cancer Institute, Victoria, Australia. (RW, DSB, RJH)
Centre for Clinical Neuroscience and Neurological Research, St. Vincent’s Hospital, Melbourne, Australia. (MJC)
ID# 1539
Tags: Adolescent, Adult, Aged, Australia/epidemiology, Chronic Disease, Cohort Studies, Cost-Benefit Analysis, Female, Fluorodeoxyglucose F18/diagnostic use/economics, Humans, Male, Middle Aged, Partial Epilepsies/economics/epidemiology/radionuclide imaging/surgery, Positron-Emission Tomography (PET)/economics, Preoperative Care/economics, Prevalence, Radiopharmaceuticals/diagnostic use/economics